33 results
10-Q
2024 Q1
EX-31.1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
European Union portal and database for clinical trials foreseen by the regulation, through an independent audit. The regulation becomes applicable six months … to address our internal controls and related procedures. In connection with the audit and review, as applicable, of our financial statements for the years
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
European Union portal and database for clinical trials foreseen by the regulation, through an independent audit. The regulation becomes applicable six months … to address our internal controls and related procedures. In connection with the audit and review, as applicable, of our financial statements for the years
10-K
2023 FY
EX-31.1
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
All
10-K
2023 FY
EX-31.2
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
All
10-K
qgynz6u i7x
16 Apr 24
Annual report
4:48pm
8-K
EX-99.1
kzwrff s1dfc1
9 Apr 24
Chromocell Issues Letter to Stockholders from Chief Executive Officer
8:30am
NT 10-K
fpnwawrn x6uho
1 Apr 24
Notice of late annual filing
9:00am
8-K
EX-1.1
wk7jvjp
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
u6j3sew 69s
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
8bay11w 2pid9h1kyuef
20 Feb 24
Prospectus supplement with pricing info
5:28pm